Erden, A. 2023. TOFACITINIB: CURRENT CONSIDERATIONS IN THE MANAGEMENT OF IMMUNE INFLAMMATORY DISORDERS. Rheumatology Quarterly , vol.0 .

Erden, A., (2023). TOFACITINIB: CURRENT CONSIDERATIONS IN THE MANAGEMENT OF IMMUNE INFLAMMATORY DISORDERS. Rheumatology Quarterly , vol.0.

Erden, ABDULSAMET. "TOFACITINIB: CURRENT CONSIDERATIONS IN THE MANAGEMENT OF IMMUNE INFLAMMATORY DISORDERS," Rheumatology Quarterly , vol.0, 2023

Erden, ABDULSAMET. "TOFACITINIB: CURRENT CONSIDERATIONS IN THE MANAGEMENT OF IMMUNE INFLAMMATORY DISORDERS." Rheumatology Quarterly , vol.0, 2023

Erden, A. (2023) . "TOFACITINIB: CURRENT CONSIDERATIONS IN THE MANAGEMENT OF IMMUNE INFLAMMATORY DISORDERS." Rheumatology Quarterly , vol.0.

@article{article, author={ABDULSAMET ERDEN}, title={TOFACITINIB: CURRENT CONSIDERATIONS IN THE MANAGEMENT OF IMMUNE INFLAMMATORY DISORDERS}, journal={Rheumatology Quarterly}, year=2023}